Bouvel Investment Partners’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69M Sell
48,852
-22,972
-32% -$2.1M 1.06% 40
2026
Q1
$2.66M Buy
71,824
+18,028
+34% +$577K 0.77% 48
2025
Q4
$1.09M Sell
53,796
-1,281
-2% -$31K 0.31% 71
2025
Q3
$1.66M Buy
55,077
+275
+0.5% +$5.96K 0.51% 62
2025
Q2
$709K Sell
54,802
-3,431
-6% -$32.7K 0.24% 67
2025
Q1
$748K Buy
58,233
+644
+1% +$7.12K 0.28% 73
2024
Q4
$958K Sell
57,589
-644
-1% -$8.59K 0.35% 67
2024
Q3
$748K Buy
58,233
+1,981
+4% +$28.6K 0.28% 73
2024
Q2
$628K Buy
56,252
+1,658
+3% +$19.3K 0.24% 73
2024
Q1
$677K Buy
54,594
+25,227
+86% +$420K 0.29% 69
2023
Q4
$779K Buy
+29,367
New +$857K 0.36% 70

Other funds holding AEHR

Bouvel Investment Partners's AEHR Position: Q2 2026 in Review

Bouvel Investment Partners reduced its Aehr Test Systems (AEHR) stake by 32% in Q2 2026, selling an estimated $2.1M and leaving 48,852 shares worth $4.69M. The position accounts for 1.06% of the portfolio, ranked #40.

Bouvel Investment Partners first reported a position in AEHR in Q4 2023 and has held it in 11 quarters since. 35 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Bouvel Investment Partners held 48,852 shares of Aehr Test Systems worth $4.69M as of Q2 2026.
  • Bouvel Investment Partners sold 22,972 Aehr Test Systems shares in Q2 2026, an estimated $2.1M.
  • Aehr Test Systems made up 1.06% of Bouvel Investment Partners's portfolio in Q2 2026, its #40 holding.
  • Bouvel Investment Partners first reported a position in Aehr Test Systems in Q4 2023 and has held it in 11 quarters since.
  • 35 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Bouvel Investment Partners's 13F filing for Q2 2026, filed 17 Jul 2026.